Human papillomavirus DNA testing for cervical cancer screening: Practical aspects in developing countries

Molecular Diagnosis and Therapy

Volumn 14, Issue 4, 2010, Pages 215-222

  Belinson, Suzanne E ^a   Belinson, Jerome L ^a  

^a Preventive Oncology International Inc   (United States)

Author keywords

Cervical cancer, diagnosis; Diagnostic Screening; Human papillomavirus infections

Indexed keywords

VIRUS DNA;

CANCER SCREENING; CRYOTHERAPY; HIGH RISK PATIENT; HUMAN; NONHUMAN; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CANCER; WART VIRUS;

HUMAN PAPILLOMAVIRUS;

EID: 77956236089     PISSN: 11771062     EISSN: 11792000     Source Type: Journal    
DOI: 10.1007/bf03256376     Document Type: Review

References (37)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108
2. Sankaranarayanan R, Wesley R, Somanathan T, et al. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors. Cancer 1998; 83: 2150-2156
3. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.J Pathol 1999; 189: 12-19
4. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1987; 1: 1247-1249
5. Altekruse SF, Kosary CL, Krapcho M, et al., editors. SEER cancer statistics review 1975-2007. Bethesda (MD): National Cancer Institute, 2010 Jun 30 [online]. Available from URL: http://seer.cancer.gov/csr/1975-2007/index. html [Accessed 2010 Aug 3]
6. Papanicolaou GN, Traut HF. The diagnostic value of vaginal smears in car-cinoma of the uterus. Am J Obstet Gynecol 1941; 42: 193-206
7. Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006; 119: 1095-1101
8. Sankaranarayanan R, Esmy PO, Rajkumar R, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet 2007; 370: 398-406
9. Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009; 360: 1385-1394
10. Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in in-vasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003; 88: 63-73
11. Clifford GM, Smith JS, Aguado T, et al. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis.Br J Cancer 2003; 89: 101-105
12. Clifford GM, Rana RK, Franceschi S, et al. Human papillomavirus geno-type distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 1157-1164
13. Kulasingam SL, Myers ER. Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. JAMA 2003; 290: 781-789
14. Belinson JL, Hu S, Niyazi M, et al. Prevalence of type-specific human papil-lomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: implications for vaginal self-collection. Int J Cancer 2010; 127: 1151-1157
15. Belinson J, Qiao YL, Pretorius R, et al. Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001; 83: 439-444
16. Belinson JL, Qiao YL, Pretorius RG, et al. Shanxi Province Cervical Cancer Screening Study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology. Int J Gynecol Cancer 2003; 13: 819-826
17. Belinson JL, Hui D, Wang GP, et al. Evaluation of the POI/NIH cervico-vaginal self-sampler for HPV from the SHENCCAST II trial [abstract]. 4th Biennial Meeting, Asia Oceania Research Organisation on Genital Infections and Neoplasia (AOGIN); 2010 Mar 26-28; New Delhi
18. Tisci S, Shen YH, Fife D, et al. Patient acceptance of self-sampling for human papillomavirus in rural China. J Low Genit Tract Dis 2003; 7: 107-116
19. Nieves-Arriba L, Enerson C, Belinson S, et al. Mexican Cervical Cancer Screening Study II: acceptability of a new self-sampling device [abstract no. 43]. 41st Annual Meeting, Society Of Gynecologic Oncologists; 2010 Mar 14-17; San Francisco (CA)
20. Naucler P,RydW,TornbergS,etal. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 2007; 357: 1589-1597
21. Mayrand MH, Duarte-Franco E, Rodrigues I, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007; 357: 1579-1588
22. Cuzick J, Szarewski A, Mesher D, et al. Long-term follow-up of cervical ab-normalities among women screened by HPV testing and cytology: results from the Hammersmith Study. Int J Cancer 2008; 122: 2294-2300
23. Shi JF, Belinson JL, Zhao FH, et al. Human papillomavirus testing for cervical cancer screening: results from a 6-year prospective study in rural China. Am J Epidemiol 2009; 170: 708-716
24. Dillner J, Rebolj M, Birembaut P, et al. Long term predictive values of cyto-logy and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 2008; 337: a1754
25. Franceschi S, Herrero R, Clifford GM, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 2006; 119: 2677-2684
26. Qiao YL, Sellors JW, Eder PS, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008; 9: 929-936
27. Soderlund-Strand A, Dillner J, Carlson J. High-throughput genotyping of oncogenic human papilloma viruses with MALDI-TOF mass spectrometry. Clin Chem 2008; 54 (1): 86-92
28. Chirenje ZM, Rusakaniko S, Akino V, et al. A randomised clinical trial of loop electrosurgical excision procedure (LEEP) versus cryotherapy in the treatment of cervical intraepithelial neoplasia. J Obstet Gynaecol 2001; 21: 617-621
29. Chamot E, Kristensen S, Stringer JS, et al. Are treatments for cervical pre-cancerous lesions in less-developed countries safe enough to promote scaling-up of cervical screening programs? A systematic review. BMC Womens Health 2010; 10: 11
30. Mitchell MF, Tortolero-Luna G, Cook E, et al. A randomized clinical trial of cryotherapy, laser vaporization, and loop electrosurgical excision for treatment of squamous intraepithelial lesions of the cervix. Obstet Gynecol 1998; 92: 737-744
31. Martin-Hirsch PP, Paraskevaidis E, Bryant A, et al. Surgery for cervical intra-epithelial neoplasia. Cochrane Database Syst Rev 2010; (6): CD001318
32. Wulan N, Rasool N, Belinson SE, et al. Study of the diagnostic efficacy of real-time optical coherence tomography as an adjunct to unaided visual inspection with acetic acid for the diagnosis of preinvasive and invasive neoplasia of the uterine cervix. Int J Gynecol Cancer 2010; 20: 422-427
33. Belinson JL, Pretorius RG, Enerson C, et al. The Mexican Cervical Cancer Screening Trial: self-sampling for human papillomavirus with unaided visual inspection as a secondary screen. Int J Gynecol Cancer 2009; 19: 27-32
34. Day SP, Hudson A, Mast A, et al. Analytical performance of the investiga-tional use only Cervista HPV HR test as determined by a multi-center study. J Clin Virol 2009; 45 Suppl. 1: S63-72
35. Thai H, Rangwala S,Gay T, et al. An HPV 16, 18, and45 genotyping test based on Hybrid Capture technology. J Clin Virol 2009; 45 Suppl. 1: S93-7
36. Kraus I, Molden T, Holm R, et al. Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas. J Clin Microbiol 2006; 44: 1310-1317
37. Global Polio Eradication Initiative. The history [online]. Available from URL http://www.polioeradication.org/history.asp [Accessed 2010 Jul 27]